Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules (Q33388644)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules |
scientific article |
Statements
1 reference
Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules (English)
1 reference
Ute Hoch
1 reference
Ranjana H Advani
1 reference
Herbert I Hurwitz
1 reference
Michael S Gordon
1 reference
Scot W Ebbinghaus
1 reference
David S Mendelson
1 reference
Heather A Wakelee
1 reference
Jeffrey A Silverman
1 reference
Nancy A Havrilla
1 reference
Craig J Berman
1 reference
Judith A Fox
1 reference
Roberta S Allen
1 reference
Daniel C Adelman
1 reference
16 March 2010
1 reference
1 reference
16
1 reference
2167-2175
1 reference
Identifiers
1 reference
1 reference